首页 > 最新文献

Experimental oncology最新文献

英文 中文
APPENDICULAR MUCINOUS CYSTADENOMA AND CYSTOADENOSARCOMA IN GYNECOLOGICAL PRACTICE. CLINICAL CASES AND LITERATURE REVIEW. 阑尾粘液性囊腺瘤和囊腺肉瘤在妇科实践中的应用。临床病例及文献复习。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.108
V O Sklyarova, V V Maksymyuk, R A Chajkivskyj, O V Prykupenko, O M Nepyivoda, T Yu Rozhanskyi, Yu T Martyn, V R Chajkivska

Tumors of the right uterine appendages cannot always be distinguished from mucous neoplasms of the appendix (MA) at the preoperative stage. According to the literature, MA is traditionally considered more common in women than in men at the age of 50 years, with a ratio of 4:1. We have identified 2 cases of surgical treatment of MA in gynecological practice, one of mucinous cystadenoma and the other of mucinous cystadenocarcinoma. We present the visual intraoperative assessment of the appendix condition in cystadenoma and cystadenocarcinoma, clinical manifestations, diagnostic discrepancies, and operative tactics. The literature on the detection of appendicular mucocele that mimics ovarian tumor formations in women has been reviewed. The features of diagnostics and possible diagnostic errors were summarized. Diagnostic laparoscopy, visual and operative clinical experience of the surgeon, and cytological and histological examinations of intra- and postoperative results allow for an adequate treatment. It is advisable that the stages and course of appendectomy be reviewed by operating gynecologists and, if necessary, general surgeons.

在术前阶段,右子宫附属物的肿瘤不能总是与阑尾粘液瘤(MA)区分。根据文献,传统上认为MA在50岁时女性比男性更常见,比例为4:1。我们在妇科实践中发现了2例MA的手术治疗,一例为粘液囊腺瘤,另一例为粘液囊腺癌。我们提出术中对阑尾囊腺瘤和囊腺癌的视觉评估、临床表现、诊断差异和手术策略。文献检测阑尾黏液囊肿,模仿卵巢肿瘤形成的妇女已经审查。总结了诊断的特点和可能出现的诊断错误。诊断性腹腔镜检查,外科医生的视觉和手术临床经验,以及术中和术后结果的细胞学和组织学检查允许适当的治疗。建议由妇科外科医生检查阑尾切除术的阶段和过程,如有必要,由普通外科医生检查。
{"title":"APPENDICULAR MUCINOUS CYSTADENOMA AND CYSTOADENOSARCOMA IN GYNECOLOGICAL PRACTICE. CLINICAL CASES AND LITERATURE REVIEW.","authors":"V O Sklyarova, V V Maksymyuk, R A Chajkivskyj, O V Prykupenko, O M Nepyivoda, T Yu Rozhanskyi, Yu T Martyn, V R Chajkivska","doi":"10.15407/exp-oncology.2025.01.108","DOIUrl":"10.15407/exp-oncology.2025.01.108","url":null,"abstract":"<p><p>Tumors of the right uterine appendages cannot always be distinguished from mucous neoplasms of the appendix (MA) at the preoperative stage. According to the literature, MA is traditionally considered more common in women than in men at the age of 50 years, with a ratio of 4:1. We have identified 2 cases of surgical treatment of MA in gynecological practice, one of mucinous cystadenoma and the other of mucinous cystadenocarcinoma. We present the visual intraoperative assessment of the appendix condition in cystadenoma and cystadenocarcinoma, clinical manifestations, diagnostic discrepancies, and operative tactics. The literature on the detection of appendicular mucocele that mimics ovarian tumor formations in women has been reviewed. The features of diagnostics and possible diagnostic errors were summarized. Diagnostic laparoscopy, visual and operative clinical experience of the surgeon, and cytological and histological examinations of intra- and postoperative results allow for an adequate treatment. It is advisable that the stages and course of appendectomy be reviewed by operating gynecologists and, if necessary, general surgeons.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"108-114"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HOMOERIODICTYOL INHIBITS SURVIVAL AND MIGRATION OF ANDROGEN-RESISTANT PROSTATE CANCER CELLS IN VITRO. 异戊二醇抑制雄激素抵抗前列腺癌细胞的体外存活和迁移。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.034
A Güvenç, K Üstündağ, A Yörüyüş, R Serttas, S Erdogan

Background: Flavonoids, naturally occurring compounds found in plant-based products, are being investigated as potential non-invasive treatments due to their ability to inhibit cell growth, induce apoptosis, and prevent cell migration.

Aim: This study aims to investigate the effects of homoeriodictyol, a member of the flavanone group, both alone and in combination with docetaxel on the survival, apoptosis, migration, and proliferation of prostate cancer cells.

Materials and methods: Androgen-resistant prostate cancer PC3 cells were treated with various concentrations of homoeriodictyol, docetaxel, or a combination of both for 72 h. The treatment effects on cell survival, migration, apoptosis, and gene expression were evaluated using the MTT test, wound healing assay, Hoechst staining, and realtime PCR.

Results: Homoeriodictyol induced apoptosis in PC3 cells in a concentration-dependent manner, with a more potent effect in combination with docetaxel. Apoptosis occurred through both intrinsic and extrinsic caspase pathways, leading to the upregulation of CASP3, CASP8, TP53, BAX, and CYCS, and downregulation of BCL2 mRNA expression. Homoeriodictyol also exhibited antimigratory effects via upregulating CDH1, while decreasing CDH2 expression levels. It suppressed epithelial-mesenchymal transition by downregulating the expression of TWIST, SNAIL, and ZEB1, which correlated with the observed antimigratory effects in wound healing assays.

Conclusion: Homoeriodictyol exerted potent effects and inhibited prostate cancer cell proliferation and migration, especially when used in combination with docetaxel.

背景:黄酮类化合物是一种在植物性产品中发现的天然化合物,由于其抑制细胞生长、诱导细胞凋亡和阻止细胞迁移的能力,正被研究作为潜在的非侵入性治疗方法。目的:本研究旨在探讨黄酮组成员同戊二醇单独或联合多西他赛对前列腺癌细胞存活、凋亡、迁移和增殖的影响。材料和方法:用不同浓度的异碘二醇、多西他赛或两者联合处理雄激素耐药前列腺癌PC3细胞72小时。通过MTT试验、伤口愈合试验、Hoechst染色和实时PCR评估处理对细胞存活、迁移、凋亡和基因表达的影响。结果:异戊二醇诱导PC3细胞凋亡呈浓度依赖性,且与多西紫杉醇联用效果更明显。凋亡通过内源性和外源性caspase途径发生,导致CASP3、CASP8、TP53、BAX和CYCS上调,BCL2 mRNA表达下调。同戊二醇还通过上调CDH1表达水平,降低CDH2表达水平,表现出抗迁移作用。它通过下调TWIST、SNAIL和ZEB1的表达来抑制上皮-间质转化,这与在伤口愈合试验中观察到的抗迁移作用有关。结论:异戊二醇具有抑制前列腺癌细胞增殖和迁移的作用,特别是与多西他赛联合使用时。
{"title":"HOMOERIODICTYOL INHIBITS SURVIVAL AND MIGRATION OF ANDROGEN-RESISTANT PROSTATE CANCER CELLS IN VITRO.","authors":"A Güvenç, K Üstündağ, A Yörüyüş, R Serttas, S Erdogan","doi":"10.15407/exp-oncology.2025.01.034","DOIUrl":"10.15407/exp-oncology.2025.01.034","url":null,"abstract":"<p><strong>Background: </strong>Flavonoids, naturally occurring compounds found in plant-based products, are being investigated as potential non-invasive treatments due to their ability to inhibit cell growth, induce apoptosis, and prevent cell migration.</p><p><strong>Aim: </strong>This study aims to investigate the effects of homoeriodictyol, a member of the flavanone group, both alone and in combination with docetaxel on the survival, apoptosis, migration, and proliferation of prostate cancer cells.</p><p><strong>Materials and methods: </strong>Androgen-resistant prostate cancer PC3 cells were treated with various concentrations of homoeriodictyol, docetaxel, or a combination of both for 72 h. The treatment effects on cell survival, migration, apoptosis, and gene expression were evaluated using the MTT test, wound healing assay, Hoechst staining, and realtime PCR.</p><p><strong>Results: </strong>Homoeriodictyol induced apoptosis in PC3 cells in a concentration-dependent manner, with a more potent effect in combination with docetaxel. Apoptosis occurred through both intrinsic and extrinsic caspase pathways, leading to the upregulation of CASP3, CASP8, TP53, BAX, and CYCS, and downregulation of BCL2 mRNA expression. Homoeriodictyol also exhibited antimigratory effects via upregulating CDH1, while decreasing CDH2 expression levels. It suppressed epithelial-mesenchymal transition by downregulating the expression of TWIST, SNAIL, and ZEB1, which correlated with the observed antimigratory effects in wound healing assays.</p><p><strong>Conclusion: </strong>Homoeriodictyol exerted potent effects and inhibited prostate cancer cell proliferation and migration, especially when used in combination with docetaxel.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"34-43"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FEATURES OF L-ARGININE-CITRULLINE CYCLE FUNCTIONING IN PATIENTS WITH MULTIPLE MYELOMA WITH CONCOMITANT CORONARY HEART DISEASE. 多发性骨髓瘤合并冠心病患者l -精氨酸-瓜氨酸循环功能的特点
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.076
V L Ostrovskyi, I M Skrypnyk, G S Maslova ., O A Shaposhnyk

Background: Disorders of the L-arginine-citrulline cycle affect the functioning of the cardiovascular system. Cancerinduced augmentation of arginase activity stimulates the biotransformation of L-arginine to form polyamines, which causes NO deficiency and increases the risk of endothelial dysfunction in the category of high-risk patients for developing cytostatic-induced cardiotoxicity. The aim was to investigate features of L-arginine-citrulline cycle functioning in patients with multiple myeloma (MM) and concomitant coronary artery disease (CAD) during chemotherapy (CT).

Materials and methods: 42 patients with MM progression were examined and divided into 2 groups: group І (n = 20) - patients without CAD and group II (n = 22) - patients with CAD. The concentrations of L-arginine and citrulline and the activity of arginase in the blood serum of the patients were measured before and after the 1st and 5th courses of chemotherapy.

Results: Before chemotherapy, in patients of both groups, the blood serum level of L-arginine decreased, while the activity of arginase and the level of citrulline increased compared to healthy individuals. In patients of group II, the level of citrulline was higher than in patients of group I. After the 5th course of chemotherapy, L-arginine content in patients of both groups increased and citrulline levels decreased compared to the initial examination.

Conclusions: The progression of MM was accompanied by a decrease in the blood serum content of L-arginine along with an increase in the arginase activity in the blood serum compared to practically healthy individuals. An increase in the cumulative dose of cytostatics during CT in the MM patients with concomitant CAD led to a decrease in the content of L-arginine in the blood serum with a simultaneous increase in the content of citrulline compared to corresponding levels in MM patients without concomitant CAD.

背景:l -精氨酸-瓜氨酸循环紊乱会影响心血管系统的功能。癌症诱导的精氨酸酶活性增强刺激l -精氨酸的生物转化形成多胺,导致NO缺乏,增加了发生细胞静态诱导的心脏毒性的高危患者内皮功能障碍的风险。目的是研究多发性骨髓瘤(MM)合并冠状动脉疾病(CAD)患者化疗(CT)期间l -精氨酸-瓜氨酸循环功能的特征。材料和方法:将42例MM进展患者分为2组:І组(n = 20) -无CAD患者,II组(n = 22) -有CAD患者。测定患者化疗1、5个疗程前后血清l -精氨酸、瓜氨酸浓度及精氨酸酶活性。结果:化疗前,两组患者血清l -精氨酸水平均较健康人降低,精氨酸酶活性和瓜氨酸水平均较健康人升高。II组患者瓜氨酸水平高于i组患者。化疗第5个疗程后,两组患者的l -精氨酸含量较初检升高,瓜氨酸水平下降。结论:与实际健康个体相比,MM的进展伴随着血清中l -精氨酸含量的降低和血清中精氨酸酶活性的增加。合并CAD的MM患者CT期间细胞抑制剂累积剂量的增加导致血清中l -精氨酸含量下降,同时瓜氨酸含量与未合并CAD的MM患者的相应水平相比增加。
{"title":"FEATURES OF L-ARGININE-CITRULLINE CYCLE FUNCTIONING IN PATIENTS WITH MULTIPLE MYELOMA WITH CONCOMITANT CORONARY HEART DISEASE.","authors":"V L Ostrovskyi, I M Skrypnyk, G S Maslova ., O A Shaposhnyk","doi":"10.15407/exp-oncology.2025.01.076","DOIUrl":"10.15407/exp-oncology.2025.01.076","url":null,"abstract":"<p><strong>Background: </strong>Disorders of the L-arginine-citrulline cycle affect the functioning of the cardiovascular system. Cancerinduced augmentation of arginase activity stimulates the biotransformation of L-arginine to form polyamines, which causes NO deficiency and increases the risk of endothelial dysfunction in the category of high-risk patients for developing cytostatic-induced cardiotoxicity. The aim was to investigate features of L-arginine-citrulline cycle functioning in patients with multiple myeloma (MM) and concomitant coronary artery disease (CAD) during chemotherapy (CT).</p><p><strong>Materials and methods: </strong>42 patients with MM progression were examined and divided into 2 groups: group І (n = 20) - patients without CAD and group II (n = 22) - patients with CAD. The concentrations of L-arginine and citrulline and the activity of arginase in the blood serum of the patients were measured before and after the 1st and 5th courses of chemotherapy.</p><p><strong>Results: </strong>Before chemotherapy, in patients of both groups, the blood serum level of L-arginine decreased, while the activity of arginase and the level of citrulline increased compared to healthy individuals. In patients of group II, the level of citrulline was higher than in patients of group I. After the 5th course of chemotherapy, L-arginine content in patients of both groups increased and citrulline levels decreased compared to the initial examination.</p><p><strong>Conclusions: </strong>The progression of MM was accompanied by a decrease in the blood serum content of L-arginine along with an increase in the arginase activity in the blood serum compared to practically healthy individuals. An increase in the cumulative dose of cytostatics during CT in the MM patients with concomitant CAD led to a decrease in the content of L-arginine in the blood serum with a simultaneous increase in the content of citrulline compared to corresponding levels in MM patients without concomitant CAD.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"76-82"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REPROGRAMMING OF GLUCOSE METABOLISM IN HUMAN BREAST CANCER CELLS AFTER CO-CULTIVATION WITH BIFIDOBACTERIUM ANIMALIS. 人乳腺癌细胞与动物双歧杆菌共培养后葡萄糖代谢的重编程。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.003
T Kozak, O Lykhova, V Chekhun

Background: The ability to reorganize metabolic processes is one of the key properties of malignant cells necessary to ensure high energy needs, survival, proliferation, metastasis, and resistance to anticancer drugs. Lactic acid bacteria, in particular Bifidobacteria, are important elements of the tumor microenvironment in breast cancer (BC) and, as active lactate producers, can influence the metabolic phenotype of malignant cells.

Aim: To study the effect of B. animalis on some components of glucose metabolism pathways and the expression of proteins associated with this process in human BC cells of different molecular subtypes.

Materials and methods: The study was performed on human BC cells of the T-47D, MCF-7 (luminal subtype), and MDA-MB-231 (basal subtype) lines and live culture of Bifidobacterium animalis subsp. lactis (B. animalis). A colorimetric enzymatic technique, flow cytometry, immunocytochemical analysis, and cell viability trypan blue exclusion assay were used in the study.

Results: Co-cultivation of BC cells with B. animalis resulted in a significant (p < 0.05) increase in the glucose consumption rate by 1.2-4.7 times, lactate production by 15-115%, and LDH activity by 15-160% in BC cells compared to control cells. The most pronounced changes were observed in BC cells of the luminal subtype where they were accompanied by an increase in the expression of the GLUT1 glucose transporter by 30-80% compared to control cells. Also, after co-cultivation with B. animalis, we detected an increased expression of the STAT6 transcription factor in BC cells of all three lines.

Conclusions: Co-cultivation of BC cells with B. animalis is accompanied by an increase in glycolysis. B. animalis affected not only the biochemical components of the glucose metabolism pathway but also the expression levels of STAT6, GLUT1, and insulin receptor.

背景:重组代谢过程的能力是恶性细胞确保高能量需求、生存、增殖、转移和对抗癌药物耐药的关键特性之一。乳酸菌,特别是双歧杆菌,是乳腺癌(BC)肿瘤微环境的重要组成部分,作为活性乳酸的产生者,可以影响恶性细胞的代谢表型。目的:研究动物双歧杆菌对不同分子亚型人BC细胞糖代谢途径部分组分及相关蛋白表达的影响。材料和方法:采用T-47D、MCF-7 (luminal亚型)和MDA-MB-231 (basal亚型)的人BC细胞和动物双歧杆菌亚种的活培养进行研究。乳酸菌(B. animal);本研究采用比色酶技术、流式细胞术、免疫细胞化学分析和细胞活力台盼蓝排除法。结果:与动物双歧杆菌共培养,与对照细胞相比,BC细胞的葡萄糖消耗率提高了1.2-4.7倍,乳酸产量提高了15-115%,LDH活性提高了15-160% (p < 0.05)。在luminal亚型的BC细胞中观察到最明显的变化,与对照细胞相比,它们伴随着GLUT1葡萄糖转运蛋白表达增加30-80%。此外,在与B. animal alis共同培养后,我们检测到所有三种细胞系的BC细胞中STAT6转录因子的表达增加。结论:BC细胞与动物双歧杆菌的共同培养伴随着糖酵解的增加。B.动物不仅影响糖代谢途径的生化成分,还影响STAT6、GLUT1和胰岛素受体的表达水平。
{"title":"REPROGRAMMING OF GLUCOSE METABOLISM IN HUMAN BREAST CANCER CELLS AFTER CO-CULTIVATION WITH BIFIDOBACTERIUM ANIMALIS.","authors":"T Kozak, O Lykhova, V Chekhun","doi":"10.15407/exp-oncology.2025.01.003","DOIUrl":"10.15407/exp-oncology.2025.01.003","url":null,"abstract":"<p><strong>Background: </strong>The ability to reorganize metabolic processes is one of the key properties of malignant cells necessary to ensure high energy needs, survival, proliferation, metastasis, and resistance to anticancer drugs. Lactic acid bacteria, in particular Bifidobacteria, are important elements of the tumor microenvironment in breast cancer (BC) and, as active lactate producers, can influence the metabolic phenotype of malignant cells.</p><p><strong>Aim: </strong>To study the effect of B. animalis on some components of glucose metabolism pathways and the expression of proteins associated with this process in human BC cells of different molecular subtypes.</p><p><strong>Materials and methods: </strong>The study was performed on human BC cells of the T-47D, MCF-7 (luminal subtype), and MDA-MB-231 (basal subtype) lines and live culture of Bifidobacterium animalis subsp. lactis (B. animalis). A colorimetric enzymatic technique, flow cytometry, immunocytochemical analysis, and cell viability trypan blue exclusion assay were used in the study.</p><p><strong>Results: </strong>Co-cultivation of BC cells with B. animalis resulted in a significant (p < 0.05) increase in the glucose consumption rate by 1.2-4.7 times, lactate production by 15-115%, and LDH activity by 15-160% in BC cells compared to control cells. The most pronounced changes were observed in BC cells of the luminal subtype where they were accompanied by an increase in the expression of the GLUT1 glucose transporter by 30-80% compared to control cells. Also, after co-cultivation with B. animalis, we detected an increased expression of the STAT6 transcription factor in BC cells of all three lines.</p><p><strong>Conclusions: </strong>Co-cultivation of BC cells with B. animalis is accompanied by an increase in glycolysis. B. animalis affected not only the biochemical components of the glucose metabolism pathway but also the expression levels of STAT6, GLUT1, and insulin receptor.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"3-15"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DIFFUSE LARGE B-CELL LYMPHOMA COMPLICATED BY BLEEDING FROM VARICOSE VEINS OF THE STOMACH AGAINST THE BACKGROUND OF SINISTRAL PORTAL HYPERTENSION. CASE STUDY AND LITERATURE REVIEW. 弥漫性大b细胞淋巴瘤并发胃静脉曲张出血,背景为左门静脉高压。个案研究及文献回顾。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.102
D Rudyk, M Tutchenko, S Chub, M Besedinskyi, A Lovin, I Ahapchenko

Among 11,152 patients treated for complicated portal hypertension (PH) in the Kyiv Emergency Hospital in 2000- 2023, 394 (3.5%) had sinistral portal hypertension (SPH), the etiological factor of which in one patient (0.25% of SPH cases, 0.009% of all PH cases) was diffuse large B-cell lymphoma (DLBCL). We provide an example of successful surgical treatment of a patient with DLBCL that was complicated by the development of SPH with bleeding from varicose veins of the stomach. A peculiarity and difference between SPH and other forms of PH is not only the preserved patency of the portal vein and the normal gradient of portal pressure but also the preserved liver function.

2000- 2023年在基辅急救医院治疗的11152例复杂门静脉高压(PH)患者中,394例(3.5%)患有左门静脉高压(SPH),其中1例(占SPH病例的0.25%,占所有PH病例的0.009%)的病因是弥漫性大b细胞淋巴瘤(DLBCL)。我们提供一个成功手术治疗DLBCL患者的例子,该患者并发SPH并胃静脉曲张出血。SPH与其他形式的PH的特点和区别不仅在于保留了门静脉的通畅和正常的门静脉压力梯度,而且还保留了肝功能。
{"title":"DIFFUSE LARGE B-CELL LYMPHOMA COMPLICATED BY BLEEDING FROM VARICOSE VEINS OF THE STOMACH AGAINST THE BACKGROUND OF SINISTRAL PORTAL HYPERTENSION. CASE STUDY AND LITERATURE REVIEW.","authors":"D Rudyk, M Tutchenko, S Chub, M Besedinskyi, A Lovin, I Ahapchenko","doi":"10.15407/exp-oncology.2025.01.102","DOIUrl":"10.15407/exp-oncology.2025.01.102","url":null,"abstract":"<p><p>Among 11,152 patients treated for complicated portal hypertension (PH) in the Kyiv Emergency Hospital in 2000- 2023, 394 (3.5%) had sinistral portal hypertension (SPH), the etiological factor of which in one patient (0.25% of SPH cases, 0.009% of all PH cases) was diffuse large B-cell lymphoma (DLBCL). We provide an example of successful surgical treatment of a patient with DLBCL that was complicated by the development of SPH with bleeding from varicose veins of the stomach. A peculiarity and difference between SPH and other forms of PH is not only the preserved patency of the portal vein and the normal gradient of portal pressure but also the preserved liver function.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"102-107"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANALYSIS OF FACTORS INFLUENCING TREATMENT OUTCOMES OF UTERINE SARCOMAS. 影响子宫肉瘤治疗效果的因素分析。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.083
S S Davydiuk, A Y Kryzhanivska

Background: Uterine sarcoma (US) is a rare type of tumor characterized by aggressive clinical behavior and high recurrence rate. Its histopathological heterogeneity has led to a lack of consensus regarding risk factors that could guide the selection of optimal treatment strategies for this pathology.

Aim: To investigate the factors influencing treatment outcomes of US.

Materials and methods: We conducted a retrospective analysis of the treatment outcomes of 107 women diagnosed with stage I-II US from 2010 to 2023. The follow-up period ranged from 1.0 to 156.0 months. Kaplan - Meier survival curves were used for the analysis of overall survival (OS) and recurrence-free survival (RFS) rates. The correlation between the studied parameters was analyzed including relative risk (odds ratio, OR) and correlation coefficient.

Results: The assessment of OR allowed us to identify the following prognostic factors with a negative impact on the 5-year OS and RFS of patients with US: differentiation grade G3, necrotic areas in tumor tissue, lymphovascular invasion, high mitotic activity (11 or more mitoses per 10 HPF), nuclear atypia 4+, negative ER and PR statuses, and high Ki-67 expression.

Conclusions: Survival of patients with US depends on tumor grade, necrosis, and lymphovascular invasion of tumor tissue; mitotic activity and nuclear atypia; ER and PR statuses; and the level of Ki67 expression.

背景:子宫肉瘤(US)是一种罕见的肿瘤类型,具有侵袭性临床行为和高复发率。其组织病理异质性导致缺乏共识的风险因素,可以指导选择最佳的治疗策略,这种病理。目的:探讨影响US治疗效果的因素。材料和方法:我们对2010年至2023年诊断为I-II期US的107名女性的治疗结果进行了回顾性分析。随访时间为1.0 ~ 156.0个月。Kaplan - Meier生存曲线用于分析总生存率(OS)和无复发生存率(RFS)。分析研究参数之间的相关性,包括相对危险度(比值比,OR)和相关系数。结果:OR的评估使我们能够确定以下对us患者5年OS和RFS有负面影响的预后因素:分化等级G3,肿瘤组织坏死区域,淋巴血管侵袭,高有丝分裂活性(每10 HPF 11或更多有丝分裂),核异型4+,ER和PR状态阴性,Ki-67高表达。结论:US患者的生存取决于肿瘤的分级、坏死程度和肿瘤组织的淋巴血管浸润情况;有丝分裂活性与核异型性;ER和PR状态;Ki67的表达水平。
{"title":"ANALYSIS OF FACTORS INFLUENCING TREATMENT OUTCOMES OF UTERINE SARCOMAS.","authors":"S S Davydiuk, A Y Kryzhanivska","doi":"10.15407/exp-oncology.2025.01.083","DOIUrl":"10.15407/exp-oncology.2025.01.083","url":null,"abstract":"<p><strong>Background: </strong>Uterine sarcoma (US) is a rare type of tumor characterized by aggressive clinical behavior and high recurrence rate. Its histopathological heterogeneity has led to a lack of consensus regarding risk factors that could guide the selection of optimal treatment strategies for this pathology.</p><p><strong>Aim: </strong>To investigate the factors influencing treatment outcomes of US.</p><p><strong>Materials and methods: </strong>We conducted a retrospective analysis of the treatment outcomes of 107 women diagnosed with stage I-II US from 2010 to 2023. The follow-up period ranged from 1.0 to 156.0 months. Kaplan - Meier survival curves were used for the analysis of overall survival (OS) and recurrence-free survival (RFS) rates. The correlation between the studied parameters was analyzed including relative risk (odds ratio, OR) and correlation coefficient.</p><p><strong>Results: </strong>The assessment of OR allowed us to identify the following prognostic factors with a negative impact on the 5-year OS and RFS of patients with US: differentiation grade G3, necrotic areas in tumor tissue, lymphovascular invasion, high mitotic activity (11 or more mitoses per 10 HPF), nuclear atypia 4+, negative ER and PR statuses, and high Ki-67 expression.</p><p><strong>Conclusions: </strong>Survival of patients with US depends on tumor grade, necrosis, and lymphovascular invasion of tumor tissue; mitotic activity and nuclear atypia; ER and PR statuses; and the level of Ki67 expression.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"83-90"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFFECTS OF SARS-COV-2 SPIKE PROTEIN ON THE GROWTH AND PHENOTYPE OF MDA-MB-231 AND MCF-7 BREAST CANCER CELLS AND THEIR SENSITIVITY TO RADIATION-INDUCED APOPTOSIS. sars-cov-2刺突蛋白对mda-mb-231和McF-7乳腺癌细胞生长和表型的影响及其对辐射诱导凋亡的敏感性
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.024
V Brichenko, L Shlapatska, M Zavelevich, L Zvarych, V Panchenko, O Lyaskivska, O Skachkova, N Golyarnik, I Abramenko, L Buchynska, A Chumak

Background: The coronavirus infection caused by SARS-Cov-2 virus, in addition to the development of severe acute respiratory syndrome, is responsible for the development of a multiple organ dysfunction syndrome. An important aspect is its relationship with cancer. The data from clinical and experimental studies are contradictory. Thus, further studies are needed to elaborate on the potential effects of SARS-Cov-2 on cancer cells.

Aim: To study the effect of SARS-Cov-2 spike protein (SP) on the survival, phenotype, and sensitivity to radiation-induced apoptosis of breast cancer (BC) cell lines of different molecular subtype (MDA-MB-231 and MCF-7).

Materials and methods: The effects of SARS-Cov-2 SP on MDA-MB-231 and MCF-7 cells were assessed using the cell proliferation assay and flow cytometry (Ki-67, CD44, CD133, CD105, CD90, CD10, CD5, CD19, and p53). The sensitivity to radiationinduced apoptosis was evaluated by 7-amino-actinomycin D and propidium iodide staining.

Results: We did not find any significant short-term effect of SP on the proliferative activity of both studied cell lines. The phenotype of MDA-MB-231 cells cultured with SP changed toward a decrease in CD105+CD90+ and CD105+CD90- subpopulations (p < 0.0001). The p53 expression increased both in SP-treated MDA-MB-231 and MCF-7 cells. The sensitivity of SP-treated MDA-MB-231 and MCF-7 cells to radiation-induced apoptosis, although insignificantly, increased. Apoptosis in irradiated MDA-MB-231 cells was accompanied by a two-fold increase in the fluorescence intensity of p53 in SP-treated MDA-MB-231 cells. In both irradiated cultures, a significant increase in the percent of cells in S-phase after SP treatment was observed compared to SP-untreated cells.

Conclusion: Since most vaccines are based on SP expression, the obtained data might have a certain significance in the study of the effect of anti-SARS-Cov-2 vaccination on tumor growth and the sensitivity of cancer cells to cytoreduction therapies.

背景:由SARS-Cov-2病毒引起的冠状病毒感染,除发展为严重急性呼吸综合征外,还可发展为多器官功能障碍综合征。一个重要的方面是它与癌症的关系。临床研究和实验研究的数据是相互矛盾的。因此,需要进一步研究SARS-Cov-2对癌细胞的潜在影响。目的:研究SARS-Cov-2刺突蛋白(SP)对不同分子亚型(MDA-MB-231和MCF-7)乳腺癌细胞株存活、表型和辐射诱导凋亡敏感性的影响。材料和方法:采用细胞增殖试验和流式细胞术(Ki-67、CD44、CD133、CD105、CD90、CD10、CD5、CD19和p53)评估SARS-Cov-2 SP对MDA-MB-231和MCF-7细胞的影响。采用7-氨基放线菌素D和碘化丙啶染色评价放线菌对辐射诱导细胞凋亡的敏感性。结果:我们没有发现SP对两种研究细胞系的增殖活性有明显的短期影响。SP培养的MDA-MB-231细胞表型变化为CD105+CD90+和CD105+CD90-亚群减少(p < 0.0001)。sp处理的MDA-MB-231和MCF-7细胞中p53表达均升高。sp处理的MDA-MB-231和MCF-7细胞对辐射诱导的凋亡的敏感性虽然不显著,但增加了。sp处理的MDA-MB-231细胞中p53的荧光强度增加了两倍,同时辐照的MDA-MB-231细胞凋亡。在两种辐照培养中,与未处理的细胞相比,观察到SP处理后s期细胞的百分比显著增加。结论:由于大多数疫苗都是基于SP的表达,因此所获得的数据在研究抗sars - cov -2疫苗对肿瘤生长的影响以及癌细胞对细胞减少疗法的敏感性方面可能具有一定的意义。
{"title":"EFFECTS OF SARS-COV-2 SPIKE PROTEIN ON THE GROWTH AND PHENOTYPE OF MDA-MB-231 AND MCF-7 BREAST CANCER CELLS AND THEIR SENSITIVITY TO RADIATION-INDUCED APOPTOSIS.","authors":"V Brichenko, L Shlapatska, M Zavelevich, L Zvarych, V Panchenko, O Lyaskivska, O Skachkova, N Golyarnik, I Abramenko, L Buchynska, A Chumak","doi":"10.15407/exp-oncology.2025.01.024","DOIUrl":"10.15407/exp-oncology.2025.01.024","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus infection caused by SARS-Cov-2 virus, in addition to the development of severe acute respiratory syndrome, is responsible for the development of a multiple organ dysfunction syndrome. An important aspect is its relationship with cancer. The data from clinical and experimental studies are contradictory. Thus, further studies are needed to elaborate on the potential effects of SARS-Cov-2 on cancer cells.</p><p><strong>Aim: </strong>To study the effect of SARS-Cov-2 spike protein (SP) on the survival, phenotype, and sensitivity to radiation-induced apoptosis of breast cancer (BC) cell lines of different molecular subtype (MDA-MB-231 and MCF-7).</p><p><strong>Materials and methods: </strong>The effects of SARS-Cov-2 SP on MDA-MB-231 and MCF-7 cells were assessed using the cell proliferation assay and flow cytometry (Ki-67, CD44, CD133, CD105, CD90, CD10, CD5, CD19, and p53). The sensitivity to radiationinduced apoptosis was evaluated by 7-amino-actinomycin D and propidium iodide staining.</p><p><strong>Results: </strong>We did not find any significant short-term effect of SP on the proliferative activity of both studied cell lines. The phenotype of MDA-MB-231 cells cultured with SP changed toward a decrease in CD105+CD90+ and CD105+CD90- subpopulations (p < 0.0001). The p53 expression increased both in SP-treated MDA-MB-231 and MCF-7 cells. The sensitivity of SP-treated MDA-MB-231 and MCF-7 cells to radiation-induced apoptosis, although insignificantly, increased. Apoptosis in irradiated MDA-MB-231 cells was accompanied by a two-fold increase in the fluorescence intensity of p53 in SP-treated MDA-MB-231 cells. In both irradiated cultures, a significant increase in the percent of cells in S-phase after SP treatment was observed compared to SP-untreated cells.</p><p><strong>Conclusion: </strong>Since most vaccines are based on SP expression, the obtained data might have a certain significance in the study of the effect of anti-SARS-Cov-2 vaccination on tumor growth and the sensitivity of cancer cells to cytoreduction therapies.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"24-33"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ERRATUM FOR CYSTECTOMY IN METASTATIC BLADDER CANCER: FEASIBILITY, SAFETY AND OUTCOMES PUBLISHED IN EXP ONCOL 2024;46(4). 膀胱切除术治疗转移性膀胱癌的可行性、安全性和结果,发表于exp oncol 2024;46(4)。
Pub Date : 2025-07-11

Cystectomy in Metastatic Bladder Cancer: Feasibility, Safety and Outcomes Hrechko B, Voylenko O, Pikul M, Vitruk U, Stakhovsky O, Kononenko O, Semko S, Koshel D, Tymoshenko A, Buyvol O, Stakhovsky E. Exp Oncol. 2024;46(4):345-350 DOI: https://doi.org/10.15407/exp-oncology.2024.04.345.

陈建军,刘建军,刘建军,陈建军,陈建军,陈建军,陈建军。膀胱切除术治疗转移性膀胱癌的可行性、安全性和预后。中华肿瘤杂志,2014;46(4):345-350 DOI: https://doi.org/10.15407/exp-oncology.2024.04.345。
{"title":"ERRATUM FOR CYSTECTOMY IN METASTATIC BLADDER CANCER: FEASIBILITY, SAFETY AND OUTCOMES PUBLISHED IN EXP ONCOL 2024;46(4).","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cystectomy in Metastatic Bladder Cancer: Feasibility, Safety and Outcomes Hrechko B, Voylenko O, Pikul M, Vitruk U, Stakhovsky O, Kononenko O, Semko S, Koshel D, Tymoshenko A, Buyvol O, Stakhovsky E. Exp Oncol. 2024;46(4):345-350 DOI: https://doi.org/10.15407/exp-oncology.2024.04.345.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"124"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY. 体外评价丙泊西泮对cyp2c8活性的可逆性和代谢依赖性抑制作用。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.051
М Golovenko, I Valivodz, A Reder, V Larionov

Background: In oncology, drug-drug interactions (DDIs) are particularly relevant due to the complex medication regimens of cancer patients. These patients often require multiple drugs to manage both their disease and treatment-related side effects. Evaluating potential DDIs via the inhibition of CYP enzymes is crucial in drug discovery. This study aimed to assess the effect of propoxazepam on CYP2C8 activity in vitro by amodiaquine N-deethylation in human liver microsomes and to predict the likelihood of DDI through CYP activity reduction.

Materials and methods: Amodiaquine Ndeethylation was used as a marker of CYP2C8 activity. The positive controls included montelukast (1 μM) for rever sible inhibition and gemfibrozil O-glucuronide (40 μM) for metabolism-dependent inhibition. Propoxazepam was tested in both reversible and metabolism-dependent inhibition conditions being added with the substrate or pre-incubated with microsomes and NADPH, respectively. The metabolite formation was quantified by LC-MS/MS in a multiple reaction monitoring mode using the electrospray ionization technique.

Results: Propoxazepam inhibited CYP2C8 activity in a concentration-dependent manner, with IC50 values of 20.5 ± 2.2 μM for reversible inhibition and 23.1 ± 3.2 μM for metabolism-dependent inhibition. Positive controls montelukast and gemfibrozil O-glucuronide showed expected inhibition (4.4% and 12.2% of control, respectively). Propoxazepam showed low binding to microsomal protein under the experimental conditions.

Conclusion: Based on the indicators used (Ki, IC50, IC50 shift, and [I]/Ki ratios), propoxazepam is not expected to be a significant CYP2C8 inhibitor in vitro.

背景:在肿瘤学中,由于癌症患者复杂的用药方案,药物-药物相互作用(ddi)尤为重要。这些患者通常需要多种药物来控制他们的疾病和治疗相关的副作用。通过抑制CYP酶来评估潜在的ddi在药物发现中至关重要。本研究旨在通过阿莫地喹n -去乙基化评价丙泊西泮对体外人肝微粒体CYP2C8活性的影响,并通过降低CYP活性预测DDI的可能性。材料与方法:以阿莫地喹去甲基化作为CYP2C8活性的标志物。阳性对照包括孟鲁司特(1 μM)可逆抑制和吉非罗齐o -葡糖苷(40 μM)代谢依赖性抑制。在可逆和代谢依赖的抑制条件下,分别添加底物或与微粒体和NADPH预孵育丙泊西泮进行测试。采用电喷雾电离多反应监测模式,LC-MS/MS对代谢物形成进行定量分析。结果:丙泊西泮抑制CYP2C8活性呈浓度依赖性,可逆抑制的IC50值为20.5±2.2 μM,代谢依赖性抑制的IC50值为23.1±3.2 μM。阳性对照孟鲁司特和吉非罗齐o -葡萄糖醛酸酯表现出预期的抑制作用(分别为对照组的4.4%和12.2%)。实验条件下丙泊西泮与微粒体蛋白的结合较低。结论:基于所使用的指标(Ki、IC50、IC50移位和[I]/Ki比值),丙泊西泮在体外不具有显著的CYP2C8抑制剂作用。
{"title":"IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY.","authors":"М Golovenko, I Valivodz, A Reder, V Larionov","doi":"10.15407/exp-oncology.2025.01.051","DOIUrl":"10.15407/exp-oncology.2025.01.051","url":null,"abstract":"<p><strong>Background: </strong>In oncology, drug-drug interactions (DDIs) are particularly relevant due to the complex medication regimens of cancer patients. These patients often require multiple drugs to manage both their disease and treatment-related side effects. Evaluating potential DDIs via the inhibition of CYP enzymes is crucial in drug discovery. This study aimed to assess the effect of propoxazepam on CYP2C8 activity in vitro by amodiaquine N-deethylation in human liver microsomes and to predict the likelihood of DDI through CYP activity reduction.</p><p><strong>Materials and methods: </strong>Amodiaquine Ndeethylation was used as a marker of CYP2C8 activity. The positive controls included montelukast (1 μM) for rever sible inhibition and gemfibrozil O-glucuronide (40 μM) for metabolism-dependent inhibition. Propoxazepam was tested in both reversible and metabolism-dependent inhibition conditions being added with the substrate or pre-incubated with microsomes and NADPH, respectively. The metabolite formation was quantified by LC-MS/MS in a multiple reaction monitoring mode using the electrospray ionization technique.</p><p><strong>Results: </strong>Propoxazepam inhibited CYP2C8 activity in a concentration-dependent manner, with IC50 values of 20.5 ± 2.2 μM for reversible inhibition and 23.1 ± 3.2 μM for metabolism-dependent inhibition. Positive controls montelukast and gemfibrozil O-glucuronide showed expected inhibition (4.4% and 12.2% of control, respectively). Propoxazepam showed low binding to microsomal protein under the experimental conditions.</p><p><strong>Conclusion: </strong>Based on the indicators used (Ki, IC50, IC50 shift, and [I]/Ki ratios), propoxazepam is not expected to be a significant CYP2C8 inhibitor in vitro.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"51-59"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
СIRCULATING MIRNAS AS PREDICTIVE MARKERS FOR LINE I AND II NEOADJUVANT CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER. Сirculating mirnas作为三阴性乳腺癌I线和ii线新辅助化疗的预测标志物。
Pub Date : 2025-07-11 DOI: 10.15407/exp-oncology.2025.01.016
T V Borikun, V Bazas, T Zadvornyi, I Karacharova, Yu Lytovchenko, N Lukianova

Background: miRNAs have emerged as promising biomarkers for breast cancer, particularly in predicting treatment response and prognosis. Their ability to regulate gene expression and their presence in various bodily fluids make them valuable tools for personalized medicine.

Materials and methods: The study was based on a retrospective analysis of the results of the examination, treatment, and survival of 94 patients with stage II-III triple-negative breast cancer (TNBC) who underwent treatment at the Kyiv City Clinical Oncology Center during 2013-2017. miRNA expressions in blood serum were estimated using the real-time RT-PCR.

Results: The elevated levels of miR-21, -155, -199a, and -200b (p < 0.05) were linked to metastasis to regional lymph nodes, while miR-373 and -126 expression levels were associated with the tumor stage (r = 0.55 and 0.57, respectively, p < 0.05). The higher serum levels of miR-21 (> 5.4, p < 0.05), -125b (> 6.0, p < 0.05) and the lower miR-205 levels (< 2.0, p < 0.05) were associated with the poorer response to line I and II neoadjuvant chemotherapy. The serum levels of miR-21, -125b, -126, -199a, -200b, -205, and -373 were found to correlate with the overall and recurrence-free survivals in TNBC patients.

Conclusions: These findings suggest that miRNA-based biomarkers may have the potential as prognostic and predictive tools in TNBC, aiding in personalized treatment strategies.

背景:mirna已成为乳腺癌的有希望的生物标志物,特别是在预测治疗反应和预后方面。它们调节基因表达的能力,以及它们在各种体液中的存在,使它们成为个性化医疗的宝贵工具。材料和方法:该研究基于对2013-2017年在基辅市临床肿瘤中心接受治疗的94例II-III期三阴性乳腺癌(TNBC)患者的检查、治疗和生存结果的回顾性分析。实时RT-PCR检测血清中miRNA的表达。结果:miR-21、-155、-199a、-200b表达水平升高与局部淋巴结转移相关(p < 0.05), miR-373、-126表达水平升高与肿瘤分期相关(r分别为0.55、0.57,p < 0.05)。血清miR-21水平升高(>为5.4,p < 0.05), -125b水平升高(>为6.0,p < 0.05), miR-205水平降低(< 2.0,p < 0.05)与I线和II线新辅助化疗反应较差相关。发现血清miR-21、-125b、-126、-199a、-200b、-205和-373水平与TNBC患者的总生存率和无复发生存率相关。结论:这些发现表明,基于mirna的生物标志物可能具有作为TNBC预后和预测工具的潜力,有助于个性化治疗策略。
{"title":"СIRCULATING MIRNAS AS PREDICTIVE MARKERS FOR LINE I AND II NEOADJUVANT CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER.","authors":"T V Borikun, V Bazas, T Zadvornyi, I Karacharova, Yu Lytovchenko, N Lukianova","doi":"10.15407/exp-oncology.2025.01.016","DOIUrl":"10.15407/exp-oncology.2025.01.016","url":null,"abstract":"<p><strong>Background: </strong>miRNAs have emerged as promising biomarkers for breast cancer, particularly in predicting treatment response and prognosis. Their ability to regulate gene expression and their presence in various bodily fluids make them valuable tools for personalized medicine.</p><p><strong>Materials and methods: </strong>The study was based on a retrospective analysis of the results of the examination, treatment, and survival of 94 patients with stage II-III triple-negative breast cancer (TNBC) who underwent treatment at the Kyiv City Clinical Oncology Center during 2013-2017. miRNA expressions in blood serum were estimated using the real-time RT-PCR.</p><p><strong>Results: </strong>The elevated levels of miR-21, -155, -199a, and -200b (p < 0.05) were linked to metastasis to regional lymph nodes, while miR-373 and -126 expression levels were associated with the tumor stage (r = 0.55 and 0.57, respectively, p < 0.05). The higher serum levels of miR-21 (> 5.4, p < 0.05), -125b (> 6.0, p < 0.05) and the lower miR-205 levels (< 2.0, p < 0.05) were associated with the poorer response to line I and II neoadjuvant chemotherapy. The serum levels of miR-21, -125b, -126, -199a, -200b, -205, and -373 were found to correlate with the overall and recurrence-free survivals in TNBC patients.</p><p><strong>Conclusions: </strong>These findings suggest that miRNA-based biomarkers may have the potential as prognostic and predictive tools in TNBC, aiding in personalized treatment strategies.</p>","PeriodicalId":94318,"journal":{"name":"Experimental oncology","volume":"47 1","pages":"16-23"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1